A new examine from the POINT venture and KORFOR exhibits that the usage of the sturdy agony-relieving opioid oxycodone has drastically amplified in Norwegian hospitals and first healthcare companies over the past 10 several years. The examine has become revealed inside the European Journal of Discomfort.
We understand that people suffering from Serious soreness require superior remedy. Using opioids for chronic, non-cancer linked discomfort may well seem proper from the short-term, but can frequently have adverse penalties for both of those the person and Modern society in the long run.
This research identified key dissimilarities in full opioid use and compound-precise prescribing designs, reflecting various ache administration procedures throughout Scandinavia. Altering use styles propose evolving prescribing techniques and feasible shifts during the goal team for opioid ache therapy.
En norsk studie viser en markant økning i bruken av oksykodon i hele helsetjenesten. Forskerne har analysert utviklingen i bruk av morfin og oksykodon i perioden 2010 til 2021.
Ifølge Eirik Haarr har funnene flere aspekter som er relevante for både sykehusleger og fastleger, i tillegg til å ha et helsetjenesteperspektiv:
Approaches A cross-sectional layout utilising info from four Norwegian nationwide registries. Effects The yearly range of people with SUD diagnoses greater from 377 to 932 from 2010 to 2019, even though the yearly prevalence of individuals with SUD remained relatively steady at close to five%. There was a greater prevalence for all types of other mental health and fitness diagnoses between folks with a SUD prognosis, as compared to Individuals without a SUD prognosis. Conclusion The prevalence of SUD diagnoses was lower from the populace working with reimbursed opioids for Long-term suffering in Norway, but the amount of individuals elevated within the study interval because the number of individuals receiving reimbursed opioids greater. Sufferers with a SUD applied on typical 2 times the every day doses of opioids as compared to sufferers without having a SUD. They had been also far more very likely to have yet another psychological well being diagnosis.
Denmark and Sweden showed rising choice for “solid opioids”, when codeine-paracetamol and tramadol remained predominant in Norway. The prevalence of oxycodone consumers enhanced in Norway and Sweden, with Sweden obtaining the very best prevalence of consumers but the bottom yearly common volumes per person. Conclusions
Title your selection: Identify must be under one hundred figures Pick a collection: Unable to load your collection as a result of an error
The general goal of The purpose project is to deliver awareness to enhance therapy of people with Long-term ache to be able to stay clear of unwanted escalation of opioid therapy, greatly enhance individuals' Standard of living, and lessen the illness load.
– Jeg har nylig hatt kontakt med to uavhengige anestesiavdelinger som er i en prosess med å skifte til mer morfin og mindre oksykodon. Det at check here andre faginstanser tenker i samme baner støtter også vår anbefaling.
– If we've been to achieve altering tactics, we also have to have to examine how medical center practices affect general practitioners, states co-creator Torgeir Gilje Lid.
Derimot ser guy at endringer i anbudsavtaler kan spille en rolle: I perioden falt antall innkjøpsavtaler for morfin i sykehusene kraftig, mens antallet avtaler for oksykodon økte.
Det ble mottatt 61 svar, responsraten var 32 %. Fastlegene besvarte spørsmålene ut fra én konkret pasient de hadde søkt refusjon for. Resultater: Gjennomsnittlig dosering for every dag var seventy six mg orale morfinekvivalenter (OMEQ). Samtidig bruk av legemidler fra reseptgruppe A eller B i tillegg til opioider forekom hos fifty three % (n = 31) av pasientene. I gruppen der pasienten hadde slik samtidig bruk var forty one % (n = thirteen) av fastlegene enig eller delvis enig i at den medikamentelle behandlingen var hensiktsmessig. I gruppen der pasienten kun brukte opioider, mente seventy two % av fastlegene det samme. Konklusjon: Ordningen med individuell refusjon av opioider på blå resept mot langvarige smertetilstander er ingen garanti for at pasienten er sikret forsvarlig eller hensiktsmessig medikamentell behandling.
En ny studie fra Stage-prosjektet og KORFOR viser at bruken av det sterke smertestillende opioidet oksykodon har økt betydelig i norske sykehus og primærhelsetjenesten de siste ti årene. Studien er publisert i European Journal of Agony.